These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10775792)

  • 61. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
    Sood SK; Ballanco GA; Daum RS
    J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
    [No Abstract]   [Full Text] [Related]  

  • 62. Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
    Moxon ER; Hood D; Richards J
    Adv Exp Med Biol; 1998; 435():237-43. PubMed ID: 9498081
    [No Abstract]   [Full Text] [Related]  

  • 63. Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children.
    Lehmann D; Kakazo M; Yarsley S; Javati A; Taime J; Saleu G; Namuigi P; Alpers MP; Mendelman PM; Staub T
    P N G Med J; 1998; 41(3-4):102-11. PubMed ID: 10934551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.
    Schmitt HJ; Maechler G; Habermehl P; Knuf M; Saenger R; Begg N; Boutriau D
    Clin Vaccine Immunol; 2007 Apr; 14(4):426-34. PubMed ID: 17287313
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates.
    Lucas AH; Granoff DM
    J Immunol; 1995 Apr; 154(8):4195-202. PubMed ID: 7706754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype.
    Lenoir AA; Pandey JP; Granoff DM
    J Infect Dis; 1988 Jun; 157(6):1242-5. PubMed ID: 3131441
    [No Abstract]   [Full Text] [Related]  

  • 67. Long-term trends in invasive Haemophilus influenzae type B disease among indigenous Australian children following use of PRP-OMP and PRP-T vaccines.
    Menzies RI; Bremner KM; Wang H; Beard FH; McIntyre PB
    Pediatr Infect Dis J; 2015 Jun; 34(6):621-6. PubMed ID: 25973940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine.
    Mulholland EK; Todd J; Rowe M; Campbell H; Byass P; Vella PP; Ahonkhai VI; Greenwood BM
    Ann Trop Paediatr; 1993; 13(2):153-8. PubMed ID: 7687111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response.
    Dockrell DH; Poland GA; Steckelberg JM; Wollan PC; Strickland SR; Pomeroy C
    Vaccine; 1999 Jul; 17(22):2779-85. PubMed ID: 10438047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.
    Mulholland EK; Ahonkhai VI; Greenwood AM; Jonas LC; Lukacs LJ; Mink CM; Staub JM; Todd J; Vella PP; Greenwood BM
    Pediatr Infect Dis J; 1993 Aug; 12(8):632-7. PubMed ID: 8414774
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
    Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
    Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
    Capeding MR; Nohynek H; Käyhty H; Pascual LG; Sunico ES; Tamundong AA; Ruutu P
    Vaccine; 1998; 16(9-10):1004-8. PubMed ID: 9682351
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
    Carlsson RM; Claesson BA; Iwarson S; Lagergård T; Käyhty H
    Pediatr Infect Dis J; 1994 Jan; 13(1):27-33. PubMed ID: 8170729
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
    Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
    J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine.
    Yeh SJ; Huang LM; Chen JM; Lee PI; Chang LY; Lin YJ; Chiu HH; Lee CY
    J Formos Med Assoc; 1997 Feb; 96(2):110-5. PubMed ID: 9071836
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distribution and excretion of capsular antigen after immunization with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Sood SK; Ballanco GA; Mather FJ; Pramberg JC; Daum RS
    J Infect Dis; 1990 Mar; 161(3):574-7. PubMed ID: 2107266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
    Lenoir AA; Granoff PD; Granoff DM
    Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization.
    Singleton RJ; Davidson NM; Desmet IJ; Berner JE; Wainwright RB; Bulkow LR; Lilly CM; Siber GR
    Pediatr Infect Dis J; 1994 May; 13(5):362-7. PubMed ID: 8072817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.